Skip to main content

Table 2 Summary of standards of care by country (year 2009)

From: The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya

Malaria severity

Antimalarial drugs

Other drugs (non-anti-malarial)

Average length of stay

Other treatments

Ghana

UM

Artesunate-amodiaquine (80%); artemether-lumefantrine (20%)

Paracetamol (100%); promethazine (20%)

0

-

MO

Quinine (100%)

Paracetamol (100%); phenobarbital (10%)

7

-

MO + SA

Quinine (100%)

Gentamicin (10%); cotrimoxazole (10%)

10

Iron supplementation (100%); blood transfusion (50%)

CerM

Quinine (80%); artemether lumefantrine (20%)

Paracetamol (80%); hydrocortison (5%); phenobarbital (50%)

7

 

CerM + NS

Quinine (80%); artemether lumefantrine (20%)

Paracetamol (80%); hydrocortison (5%); phenobarbital (50%)

12

Rehabilitation visit every 10 days for 1 year

Tanzania

UM

Artesunate-Amodiaquine (75%); Quinine (25%)

Paracetamol (100%); promethazine (20%)

0

-

MO

Quinine (100%)

Paracetamol (100%)

7

-

MO + SA

Quinine (100%)

Gentamicin (10%); cotrimoxazole (10%)

7

Iron supplementation (100%); blood transfusion (50%)

CerM

Quinine (100%)

Paracetamol (60%); phenobarbital (30%)

7

 

CerM + NS

Quinine (100%)

Paracetamol (60%); phenobarbital (30%)

10

Rehabilitation visit every 15 days for 1 year

Kenya

UM

Artesunate-amodiaquine (75%); artemether-lumefantrine (25%)

Paracetamol (100%); promethazine (20%)

0

-

MO

Quinine (80%); artemether lumefantrine (20%)

Paracetamol (100%); phenobarbital (10%)

7

-

MO + SA

Quinine (80%); artemether lumefantrine (20%)

Gentamicin (10%); cotrimoxazole (10%)

9

Iron supplementation (100%); blood transfusion (50%)

CerM

Quinine (80%); artemether lumefantrine (20%)

Paracetamol (70%); phenobarbital (30%)

7

 

CerM + NS

Quinine (80%); artemether lumefantrine (20%)

Paracetamol (70%); hydrocortison (5%); phenobarbital (30%)

10

Rehabilitation visit every 15 days for 1 year

  1. Notes: UM uncomplicated malaria, MO malaria hospitalization, SA severe anemia, CerM cerebral malaria, CerM + NS cerebral malaria and neurological sequelae. In brackets, the proportion of cases receiving treatment.